Kailera Therapeutics is a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions.
Market
Obesity and related conditions
Location
Boston,
MA,
USA
Coinvestors
Atlas Venture, Bain Capital Life Sciences, RTW Investments, Lyra Capital